SE0302488D0 - New combination - Google Patents

New combination

Info

Publication number
SE0302488D0
SE0302488D0 SE0302488A SE0302488A SE0302488D0 SE 0302488 D0 SE0302488 D0 SE 0302488D0 SE 0302488 A SE0302488 A SE 0302488A SE 0302488 A SE0302488 A SE 0302488A SE 0302488 D0 SE0302488 D0 SE 0302488D0
Authority
SE
Sweden
Prior art keywords
new combination
active ingredient
kit
treatment
receptor antagonist
Prior art date
Application number
SE0302488A
Other languages
English (en)
Swedish (sv)
Inventor
Nigel Boughton-Smith
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302488A priority Critical patent/SE0302488D0/xx
Publication of SE0302488D0 publication Critical patent/SE0302488D0/xx
Priority to RU2006112423/15A priority patent/RU2338556C2/ru
Priority to AU2004271886A priority patent/AU2004271886B2/en
Priority to BRPI0414558-5A priority patent/BRPI0414558A/pt
Priority to JP2006526854A priority patent/JP2007505900A/ja
Priority to MXPA06002722A priority patent/MXPA06002722A/es
Priority to TW093127889A priority patent/TW200526199A/zh
Priority to KR1020067005446A priority patent/KR20060086942A/ko
Priority to EP04775437A priority patent/EP1663224A1/de
Priority to NZ545964A priority patent/NZ545964A/en
Priority to CA002538416A priority patent/CA2538416A1/en
Priority to PCT/SE2004/001334 priority patent/WO2005025571A1/en
Priority to US10/572,276 priority patent/US20070082930A1/en
Priority to CNA2004800284582A priority patent/CN1859911A/zh
Priority to UY28517A priority patent/UY28517A1/es
Priority to ARP040103356A priority patent/AR045783A1/es
Priority to IL173913A priority patent/IL173913A0/en
Priority to ZA200602260A priority patent/ZA200602260B/xx
Priority to IS8396A priority patent/IS8396A/is
Priority to NO20061662A priority patent/NO20061662L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0302488A 2003-09-18 2003-09-18 New combination SE0302488D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE0302488A SE0302488D0 (sv) 2003-09-18 2003-09-18 New combination
CNA2004800284582A CN1859911A (zh) 2003-09-18 2004-09-15 包括p2x7受体拮抗剂和非甾体抗炎药的药物组合物
EP04775437A EP1663224A1 (de) 2003-09-18 2004-09-15 Pharmazeutische zusammensetzung mit einem p2x7-rezeptor-antagonisten und einem nicht-steroidalen antiphlogistikum
CA002538416A CA2538416A1 (en) 2003-09-18 2004-09-15 A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug.
BRPI0414558-5A BRPI0414558A (pt) 2003-09-18 2004-09-15 composição farmacêutica compreendendo um antagonista do receptor p2x7 e uma droga antiinflamatória não esteróide
JP2006526854A JP2007505900A (ja) 2003-09-18 2004-09-15 Ｐ２ｘ７受容体アンタゴニストおよび非ステロイド性抗炎症薬を含有してなる医薬組成物
MXPA06002722A MXPA06002722A (es) 2003-09-18 2004-09-15 Composicion farmaceutica que comprende un antagonista del receptor p2x7 y un farmaco anti-inflamatorio no esteroidal.
TW093127889A TW200526199A (en) 2003-09-18 2004-09-15 New combination
KR1020067005446A KR20060086942A (ko) 2003-09-18 2004-09-15 Ｐ2ｘ7 수용체 길항제 및 비스테로이드성 소염 약물을포함하는 제약 조성물
RU2006112423/15A RU2338556C2 (ru) 2003-09-18 2004-09-15 Фармацевтическая композиция, содержащая антагонист p2x7-рецептора и нестероидное противовоспалительное лекарственное средство
NZ545964A NZ545964A (en) 2003-09-18 2004-09-15 A pharmaceutical composition comprising a P2X7 receptor antagonist and a nonsteroidal anti-inflammatory drug
AU2004271886A AU2004271886B2 (en) 2003-09-18 2004-09-15 A pharmaceutical composition comprising a P2X7 receptor antagonist and a nonsteroidal anti inflammatory drug.
PCT/SE2004/001334 WO2005025571A1 (en) 2003-09-18 2004-09-15 A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug.
US10/572,276 US20070082930A1 (en) 2003-09-18 2004-09-15 Pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti-inflammatory drug
UY28517A UY28517A1 (es) 2003-09-18 2004-09-16 Nueva combinación
ARP040103356A AR045783A1 (es) 2003-09-18 2004-09-17 Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
IL173913A IL173913A0 (en) 2003-09-18 2006-02-23 A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug
ZA200602260A ZA200602260B (en) 2003-09-18 2006-03-17 A pharmaceutical composition comprising a P2X7 receptor antagonist and a nonsteroidal anti-inflammatory drug
IS8396A IS8396A (is) 2003-09-18 2006-04-03 Lyfjablanda sem felur í sér P2X7 viðtakamótlyf ogbólgueyðandi lyf án stera
NO20061662A NO20061662L (no) 2003-09-18 2006-04-11 Farmasoytisk preparat omfattende en P2X7 reseptorantagonisk og ikke-steroid intiinfammatorisk medikament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302488A SE0302488D0 (sv) 2003-09-18 2003-09-18 New combination

Publications (1)

Publication Number Publication Date
SE0302488D0 true SE0302488D0 (sv) 2003-09-18

Family

ID=29212490

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302488A SE0302488D0 (sv) 2003-09-18 2003-09-18 New combination

Country Status (20)

Country Link
US (1) US20070082930A1 (de)
EP (1) EP1663224A1 (de)
JP (1) JP2007505900A (de)
KR (1) KR20060086942A (de)
CN (1) CN1859911A (de)
AR (1) AR045783A1 (de)
AU (1) AU2004271886B2 (de)
BR (1) BRPI0414558A (de)
CA (1) CA2538416A1 (de)
IL (1) IL173913A0 (de)
IS (1) IS8396A (de)
MX (1) MXPA06002722A (de)
NO (1) NO20061662L (de)
NZ (1) NZ545964A (de)
RU (1) RU2338556C2 (de)
SE (1) SE0302488D0 (de)
TW (1) TW200526199A (de)
UY (1) UY28517A1 (de)
WO (1) WO2005025571A1 (de)
ZA (1) ZA200602260B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI258462B (en) 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
SE0200920D0 (sv) * 2002-03-25 2002-03-25 Astrazeneca Ab Novel compounds
SE0300480D0 (sv) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
EP1644041A1 (de) * 2003-05-29 2006-04-12 AstraZeneca AB Pharmazeutische zusammensetzung mit einem p2x7 antagonisten und sulfasalazin
EP1633401A1 (de) * 2003-05-29 2006-03-15 AstraZeneca AB Pharmazeutische zusammensetzung mit einem p2x7 rezeptor-antagonisten und einem tumornekrosefaktor alpha
WO2004105796A1 (en) * 2003-05-29 2004-12-09 Astrazeneca Ab A pharmaceutical composition containing a p2x7 receptor antagonist and methotrexate
SE0302192D0 (sv) * 2003-08-08 2003-08-08 Astrazeneca Ab Novel compounds
SA05260265A (ar) * 2004-08-30 2005-12-03 استرازينيكا ايه بي مركبات جديدة
SE0402925D0 (sv) * 2004-11-30 2004-11-30 Astrazeneca Ab Novel Compounds
WO2007008155A1 (en) * 2005-07-11 2007-01-18 Astrazeneca Ab New combination 1
WO2007008157A1 (en) * 2005-07-11 2007-01-18 Astrazeneca Ab New combination 2
US20090036429A1 (en) * 2006-02-17 2009-02-05 Ohler Norman E Hydroxypiperidine Derivatives and Uses Thereof
GB0724258D0 (en) * 2007-12-12 2008-01-30 Glaxo Group Ltd Novel combinations
WO2009074518A1 (en) * 2007-12-12 2009-06-18 Glaxo Group Limited Combinations of prolinamide p2x7 modulators with further therapeutic agents
GB0919594D0 (en) 2009-11-09 2009-12-23 Glaxo Group Ltd Compounds
ES2710522T3 (es) 2009-12-08 2019-04-25 Univ Vanderbilt Procedimientos y composiciones para la extracción de venas y autotransplante
JP2013521002A (ja) 2010-03-05 2013-06-10 プレジデント アンド フェロウズ オブ ハーバード カレッジ 誘導樹状細胞組成物及びその使用
WO2013082565A1 (en) * 2011-12-02 2013-06-06 Michael Kaleko Therapies for disorders of the cornea and conjunctiva
CN111904926B (zh) * 2014-09-10 2023-10-10 Gsk消费者健康有限责任公司 局部用双氯芬酸钠组合物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3471491A (en) * 1967-08-28 1969-10-07 Squibb & Sons Inc Adamantyl-s-triazines
US3464998A (en) * 1968-03-04 1969-09-02 Searle & Co Adamantyl esters and amides of pyridinecarboxylic acids
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
US4751292A (en) * 1985-07-02 1988-06-14 The Plant Cell Research Institute, Inc. Adamantyl purines
US5399564A (en) * 1991-09-03 1995-03-21 Dowelanco N-(4-pyridyl or 4-quinolinyl) arylacetamide and 4-(aralkoxy or aralkylamino) pyridine pesticides
NZ332341A (en) * 1996-05-20 2000-05-26 Darwin Discovery Ltd Quinoline carboxamides as TNF inhibitors and as PDE-IV inhibitors
SE9704544D0 (sv) * 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
SE9704545D0 (sv) * 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
HUP0202214A3 (en) * 1999-04-09 2002-12-28 Astrazeneca Ab Adamantane derivatives, preparation and use thereof
SE9904505D0 (sv) * 1999-12-09 1999-12-09 Astra Pharma Prod Novel compounds
TWI258462B (en) * 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
EP1239856A1 (de) * 1999-12-22 2002-09-18 Pharmacia Corporation Arzneizubereitung mit verzögerter wirkstoffabgabe enthaltend einen cyclooxygenase-2 hemmer
GB0013737D0 (en) * 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
RU2347570C2 (ru) * 2001-07-02 2009-02-27 Н.В.Органон Тетрагидрохинолиновые производные
PA8557501A1 (es) * 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
WO2003042190A1 (en) * 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
SE0103836D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
US6908939B2 (en) * 2001-12-21 2005-06-21 Galderma Research & Development S.N.C. Biaromatic ligand activators of PPARγ receptors
SE0200920D0 (sv) * 2002-03-25 2002-03-25 Astrazeneca Ab Novel compounds
SE0300445D0 (sv) * 2003-02-18 2003-02-18 Astrazeneca Ab New combination
SE0300480D0 (sv) * 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
EP1644041A1 (de) * 2003-05-29 2006-04-12 AstraZeneca AB Pharmazeutische zusammensetzung mit einem p2x7 antagonisten und sulfasalazin
EP1633401A1 (de) * 2003-05-29 2006-03-15 AstraZeneca AB Pharmazeutische zusammensetzung mit einem p2x7 rezeptor-antagonisten und einem tumornekrosefaktor alpha
WO2004105796A1 (en) * 2003-05-29 2004-12-09 Astrazeneca Ab A pharmaceutical composition containing a p2x7 receptor antagonist and methotrexate
SE0302192D0 (sv) * 2003-08-08 2003-08-08 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
WO2005025571A1 (en) 2005-03-24
NZ545964A (en) 2009-09-25
ZA200602260B (en) 2007-07-25
AR045783A1 (es) 2005-11-16
RU2338556C2 (ru) 2008-11-20
AU2004271886A1 (en) 2005-03-24
IS8396A (is) 2006-04-03
IL173913A0 (en) 2006-07-05
EP1663224A1 (de) 2006-06-07
KR20060086942A (ko) 2006-08-01
NO20061662L (no) 2006-04-11
RU2006112423A (ru) 2007-11-10
TW200526199A (en) 2005-08-16
US20070082930A1 (en) 2007-04-12
MXPA06002722A (es) 2006-06-06
UY28517A1 (es) 2005-04-29
BRPI0414558A (pt) 2006-11-07
JP2007505900A (ja) 2007-03-15
CN1859911A (zh) 2006-11-08
AU2004271886B2 (en) 2008-03-20
CA2538416A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
MXPA06002722A (es) Composicion farmaceutica que comprende un antagonista del receptor p2x7 y un farmaco anti-inflamatorio no esteroidal.
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
PT1485127E (pt) Administração de agentes para o tratamento de inflamação
CY1114420T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη για την αγωγη της ψωριασης
HUE040046T2 (hu) Gyógyszerészeti készítmények és hatóanyagok beadására szolgáló eljárások
EP1513825A4 (de) Antituberkulöses arzneimittel: zusammensetzungen und verfahren
CY1118179T1 (el) Φαρμακευτικη συνθεση
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
ECSP045171A (es) Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia
CY1113894T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει ροφλουμιλαστη και λεβοκετιριζινη
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
MXPA05012705A (es) Una composicion farmaceutica que comprende un antagonista del receptor p2x7 y un factor alfa de necrosis tumoral.
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
ATE454385T1 (de) Hiv-integrase-hemmers, pharmazeutischen zusammensetzung und ihre anwendung
SE9903995D0 (sv) New combination
SE0300445D0 (sv) New combination
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
AR032422A1 (es) Uso de inhibidores de il-18 para el tratamiento y/o prevencion de la enfermedad cardiaca
EP1940432A4 (de) Entzündungshemmende zusammensetzungen und anwendungsverfahren
ATE325115T1 (de) Pyrimidinderivate als selektive cox-2-inhibitoren
ITRM20030394A0 (it) Uso dell'indometacina e derivati come farmaci antivirali e relative composizioni farmaceutiche.
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
DK1420789T3 (da) Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling
ITRM20020119A1 (it) Composizioni contenenti plgf ad uso farmaceutico e cosmetico.